Cohort profile: the TREAT Asia pediatric HIV observational database.
作者信息
Kariminia Azar, Chokephaibulkit Kulkanya, Pang Joselyn, Lumbiganon Pagakrong, Hansudewechakul Rawiwan, Amin Janaki, Kumarasamy Nagalingeswaran, Puthanakit Thanyawee, Kurniati Nia, Nik Yusoff Nik Khairulddin, Saphonn Vonthanak, Fong Siew Moy, Razali Kamarul, Nallusamy Revathy, Sohn Annette H, Sirisanthana Virat
机构信息
National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Australia.
出版信息
Int J Epidemiol. 2011 Feb;40(1):15-24. doi: 10.1093/ije/dyp358. Epub 2010 Jan 25.
Abstract
摘要
相似文献
1
Cohort profile: the TREAT Asia pediatric HIV observational database.队列简介：亚太地区儿童HIV观察性数据库
Int J Epidemiol. 2011 Feb;40(1):15-24. doi: 10.1093/ije/dyp358. Epub 2010 Jan 25.
2
Survival of HIV-infected children: a cohort study from the Asia-Pacific region.HIV 感染儿童的生存状况：亚太地区的一项队列研究。
J Acquir Immune Defic Syndr. 2011 Apr;56(4):365-71. doi: 10.1097/QAI.0b013e318207a55b.
3
The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database.如果在亚洲艾滋病治疗观察数据库中忽略站点水平效应，就会出现辛普森悖论。
J Clin Epidemiol. 2016 Aug;76:183-92. doi: 10.1016/j.jclinepi.2016.01.030. Epub 2016 Feb 4.
4
Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific.队列简介：PharmAccess非洲（PASER-M）和亚太地区治疗（TASER-M）监测研究，以评估撒哈拉以南非洲和亚太地区的耐药性——艾滋病毒耐药性。
Int J Epidemiol. 2012 Feb;41(1):43-54. doi: 10.1093/ije/dyq192. Epub 2010 Nov 10.
5
Brief Report: Pediatric Cancer Burden and Treatment Resources Within the Pediatric IeDEA Consortium.简报：儿科国际流行病学数据库协作组（Pediatric IeDEA Consortium）内的儿童癌症负担与治疗资源
J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):60-64. doi: 10.1097/QAI.0000000000001453.
6
A Decade of Combination Antiretroviral Treatment in Asia: The TREAT Asia HIV Observational Database Cohort.亚洲十年抗逆转录病毒联合治疗：泛亚地区HIV观察数据库队列研究
AIDS Res Hum Retroviruses. 2016 Aug;32(8):772-81. doi: 10.1089/AID.2015.0294. Epub 2016 May 3.
7
Impact of Gender on Long-Term Treatment Outcomes of Highly Active Antiretroviral Therapy (HAART) in the TREAT Asia HIV Observational Database.性别对亚太地区艾滋病治疗观察数据库中高效抗逆转录病毒疗法（HAART）长期治疗结果的影响。
AIDS Patient Care STDS. 2015 May;29(5):229-31. doi: 10.1089/apc.2014.0232. Epub 2015 Mar 16.
8
Global AIDS surveillance--Part I.全球艾滋病监测——第一部分。
Wkly Epidemiol Rec. 1998 Nov 27;73(48):373-6.
9
Cohort profile: the Canadian Observational Cohort collaboration.队列简介：加拿大观察性队列合作项目
Int J Epidemiol. 2011 Feb;40(1):25-32. doi: 10.1093/ije/dyp393. Epub 2010 Feb 15.
10
HIV/AIDS in Asia and the Pacific.亚太地区的艾滋病毒/艾滋病
BETA. 2002 Summer-Fall;15(3):23-4.
引用本文的文献
1
Clinical outcomes among HIV positive babies below 18 months of age, diagnosed under the Early Infant Diagnosis (EID) programme, India: a mixed-methods study.印度早期婴儿诊断（EID）项目下诊断出的18个月以下HIV阳性婴儿的临床结局：一项混合方法研究。
Lancet Reg Health Southeast Asia. 2025 Feb 6;34:100540. doi: 10.1016/j.lansea.2025.100540. eCollection 2025 Mar.
2
Research on Perinatal Human Immunodeficiency Virus in Asia: Data on Treatment Outcomes and Emerging Co-Morbidities from the TREAT Asia Network.亚洲围产期人类免疫缺陷病毒研究：来自 TREAT Asia 网络的治疗结果和新兴合并症数据。
Clin Perinatol. 2024 Dec;51(4):911-923. doi: 10.1016/j.clp.2024.08.008. Epub 2024 Sep 10.
3
High mortality in adolescents and young adults with perinatally-acquired HIV in Thailand during the transition to adulthood.在向成年期过渡期间，泰国围生期获得性 HIV 的青少年和年轻成年人死亡率较高。
AIDS Care. 2024 Jul;36(7):964-973. doi: 10.1080/09540121.2024.2325100. Epub 2024 Mar 6.
4
The changing characteristics of a cohort of children and adolescents living with HIV at antiretroviral therapy initiation in Asia.亚洲开始抗逆转录病毒治疗时，一组感染艾滋病毒的儿童和青少年的变化特征。
PLoS One. 2023 Sep 14;18(9):e0291523. doi: 10.1371/journal.pone.0291523. eCollection 2023.
5
Lipid and glucose abnormalities and associated factors among children living with HIV in Asia.亚洲地区 HIV 感染者儿童的血脂和血糖异常及其相关因素。
Antivir Ther. 2023 Apr;28(2):13596535231170751. doi: 10.1177/13596535231170751.
6
Disclosure of HIV status and associated clinical outcomes of children and adolescents living with HIV in Asia.亚洲地区 HIV 感染者儿童和青少年的 HIV 状况披露及相关临床结局。
AIDS Care. 2023 Dec;35(12):1928-1937. doi: 10.1080/09540121.2023.2176424. Epub 2023 Feb 15.
7
Impact of low-level viraemia on virological failure among Asian children with perinatally acquired HIV on first-line combination antiretroviral treatment: a multicentre, retrospective cohort study.低水平病毒血症对一线抗逆转录病毒治疗的亚洲围生期感染 HIV 儿童发生病毒学失败的影响：一项多中心、回顾性队列研究。
J Int AIDS Soc. 2020 Jul;23(7):e25550. doi: 10.1002/jia2.25550.
8
Determining standardized causes of death of infants, children, and adolescents living with HIV in Asia.确定亚洲 HIV 感染者婴幼儿和青少年标准化死因。
AIDS. 2020 Aug 1;34(10):1527-1537. doi: 10.1097/QAD.0000000000002583.
9
Dual Analysis of Loss to Follow-up for Perinatally HIV-Infected Adolescents Receiving Combination Antiretroviral Therapy in Asia.亚洲接受抗逆转录病毒联合治疗的围生期感染艾滋病毒的青少年随访丢失的双重分析。
J Acquir Immune Defic Syndr. 2019 Dec 15;82(5):431-438. doi: 10.1097/QAI.0000000000002184.
10
Peritransition Outcomes of Southeast Asian Adolescents and Young Adults With HIV Transferring From Pediatric to Adult Care.东南亚青少年和青年艾滋病病毒感染者从儿科转入成人护理后的过渡期结局。
J Adolesc Health. 2020 Jan;66(1):92-99. doi: 10.1016/j.jadohealth.2019.07.025. Epub 2019 Oct 15.
本文引用的文献
1
Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.基于非核苷类逆转录酶抑制剂的高效抗逆转录病毒疗法在泰国2岁及以下感染艾滋病毒儿童中的疗效。
Pediatr Infect Dis J. 2009 Mar;28(3):246-8. doi: 10.1097/INF.0b013e31818dd72b.
2
Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India.印度南部感染艾滋病毒儿童使用通用高效抗逆转录病毒疗法的安全性、耐受性和有效性。
J Trop Pediatr. 2009 Jun;55(3):155-9. doi: 10.1093/tropej/fmn080. Epub 2008 Oct 1.
3
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.撒哈拉以南非洲地区感染艾滋病毒儿童的抗逆转录病毒疗法疗效
Lancet Infect Dis. 2008 Aug;8(8):477-89. doi: 10.1016/S1473-3099(08)70180-4.
4
Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.奈韦拉平与依非韦伦治疗方案对泰国HIV感染儿童的疗效和耐受性比较
Int J Infect Dis. 2008 Nov;12(6):e33-8. doi: 10.1016/j.ijid.2007.10.008. Epub 2008 Jun 24.
5
Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes.中国儿童高效抗逆转录病毒治疗观察队列：临床、免疫学和病毒学结局的1年分析
J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):594-8. doi: 10.1097/QAI.0b013e318158c08e.
6
Cohort profile: the paediatric antiretroviral treatment programmes in lower-income countries (KIDS-ART-LINC) collaboration.队列简介：低收入国家儿童抗逆转录病毒治疗项目（KIDS-ART-LINC）合作项目
Int J Epidemiol. 2008 Jun;37(3):474-80. doi: 10.1093/ije/dym216. Epub 2007 Nov 12.
7
Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia.高效抗逆转录病毒疗法对柬埔寨HIV阳性儿童的疗效：在一项常规项目中的12个月评估。
Pediatrics. 2007 Nov;120(5):e1134-40. doi: 10.1542/peds.2006-3503. Epub 2007 Oct 22.
8
Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand.泰国感染人类免疫缺陷病毒的儿童接受四年高效抗逆转录病毒治疗后的持续免疫和病毒学疗效。
Pediatr Infect Dis J. 2007 Oct;26(10):953-6. doi: 10.1097/INF.0b013e318125720a.
9
Antiretroviral therapy in children: Indian experience.儿童抗逆转录病毒疗法：印度经验
Indian Pediatr. 2007 May;44(5):339-43.
10
Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings.在资源有限的环境中，接受基于非核苷类逆转录酶抑制剂的抗逆转录病毒疗法的幼儿中，按基线免疫状态分层的治疗结果。
Clin Infect Dis. 2007 May 1;44(9):1245-8. doi: 10.1086/513433. Epub 2007 Mar 28.
Zotero 插件